148 related articles for article (PubMed ID: 35518839)
1. Clinicopathological and Gene Mutation Analysis of 27 Cases with Extranodal Rosai-Dorfman Disease.
Tang M; Gu XZ; Wu PC; Yang XT
J Inflamm Res; 2022; 15():2775-2787. PubMed ID: 35518839
[TBL] [Abstract][Full Text] [Related]
2. NRAS Mutations May Be Involved in the Pathogenesis of Cutaneous Rosai Dorfman Disease: A Pilot Study.
Wu KJ; Li SH; Liao JB; Chiou CC; Wu CS; Chen CC
Biology (Basel); 2021 May; 10(5):. PubMed ID: 34063325
[TBL] [Abstract][Full Text] [Related]
3. Primary intraosseous Rosai-Dorfman disease: An analysis of clinicopathologic characteristics, molecular genetics, and prognostic features.
Weng X; Yang Y; Zhang M; Cai C; Sun Y; Wu X; Zhang R; Gui H; Li W; Xu Q; Liu X
Front Oncol; 2022; 12():950114. PubMed ID: 36185213
[TBL] [Abstract][Full Text] [Related]
4. Rosai-Dorfman Disease between Proliferation and Neoplasia.
Elbaz Younes I; Sokol L; Zhang L
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358690
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathologic analysis of extranodal Rosai-Dorfman disease of breast: a report of 12 cases].
Chen YP; Jiang XN; Lu JP; Zhang H; Li XQ; Chen G
Zhonghua Bing Li Xue Za Zhi; 2016 Aug; 45(8):556-60. PubMed ID: 27510782
[TBL] [Abstract][Full Text] [Related]
6. Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease.
Garces S; Medeiros LJ; Patel KP; Li S; Pina-Oviedo S; Li J; Garces JC; Khoury JD; Yin CC
Mod Pathol; 2017 Oct; 30(10):1367-1377. PubMed ID: 28664935
[TBL] [Abstract][Full Text] [Related]
7. [Cutaneous Rosai-Dorfman disease with lack of BRAF-V600, KRAS or NRAS mutations: A reactive or neoplastic disorder?].
Machado I; Alcacer Fernández-Coronado J; Requena C; Través V; Latorre Martínez N; Ortega J; Requena L; Alcacer García J
Rev Esp Patol; 2022; 55(1):52-56. PubMed ID: 34980442
[TBL] [Abstract][Full Text] [Related]
8. Three Cases of Extranodal Rosai-Dorfman Disease and Literature Review.
Zhao X; Yu D; Jin C
Open Life Sci; 2018 Jan; 13():263-268. PubMed ID: 33817092
[TBL] [Abstract][Full Text] [Related]
9. [Primary intraosseous Rosai-Dorfman disease: a clinicopathological analysis of fourteen cases].
Dong RF; Gong LH; Zhang W; Li L; Sun XQ; Zhang M; Ding Y
Zhonghua Bing Li Xue Za Zhi; 2020 Sep; 49(9):904-909. PubMed ID: 32892555
[No Abstract] [Full Text] [Related]
10. [Rosai-Dorfman disease: clinicopathologic, immunohistochemical and etiologic study of 16 cases].
Yu JB; Liu WP; Zuo Z; Tang Y; Liao DY; Ji H; Bai YQ; Li SH; Lu CQ; Luo HB
Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):33-8. PubMed ID: 17374236
[TBL] [Abstract][Full Text] [Related]
11. Primary Rosai-Dorfman disease of the central nervous system: A clinical, histological, and molecular appraisal.
Parkhi M; Chatterjee D; Kashyap D; Aggarwal A; Radotra B
Neuropathology; 2024 Mar; ():. PubMed ID: 38548480
[TBL] [Abstract][Full Text] [Related]
12. Extranodal soft tissue Rosai-Dorfman disease of the head and neck and its diagnostic difficulty.
Yajima M; Nakajima K; Hirato J; Chikamatsu K
Auris Nasus Larynx; 2016 Jun; 43(3):345-9. PubMed ID: 26526642
[TBL] [Abstract][Full Text] [Related]
13. BRAF mutation leading to central nervous system rosai-dorfman disease.
Richardson TE; Wachsmann M; Oliver D; Abedin Z; Ye D; Burns DK; Raisanen JM; Greenberg BM; Hatanpaa KJ
Ann Neurol; 2018 Jul; 84(1):147-152. PubMed ID: 30014527
[TBL] [Abstract][Full Text] [Related]
14. Extranodal rosai-dorfman disease of the bone treated with surgery and radiotherapy.
Paryani NN; Daugherty LC; O'Connor MI; Jiang L
Rare Tumors; 2014 Oct; 6(4):5531. PubMed ID: 25568748
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous Rosai-Dorfman disease: clinicopathological profiles, spectrum and evolution of 21 lesions in six patients.
Wang KH; Chen WY; Liu HN; Huang CC; Lee WR; Hu CH
Br J Dermatol; 2006 Feb; 154(2):277-86. PubMed ID: 16433797
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of the clinical characteristics and efficacy of 20 cases of extranodal Rosai-Dorfman disease in head and neck].
Cui L; Yue CL
Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(29):2284-2287. PubMed ID: 28780844
[No Abstract] [Full Text] [Related]
17. Rosai-Dorfman Disease Harboring an Activating KRAS K117N Missense Mutation.
Shanmugam V; Margolskee E; Kluk M; Giorgadze T; Orazi A
Head Neck Pathol; 2016 Sep; 10(3):394-9. PubMed ID: 26922062
[TBL] [Abstract][Full Text] [Related]
18. KRAS 117N positive Rosai-Dorfman disease with atypical features.
Jafri ZA; Reddy SP; Cassarino DS
J Cutan Pathol; 2021 Jan; 48(1):147-150. PubMed ID: 32974961
[TBL] [Abstract][Full Text] [Related]
19. Rare Presentation of Rosai-Dorfman Disease in Soft Tissue: Diagnostic Findings and Surgical Treatment.
Betini N; Munger AM; Rottmann D; Haims A; Costa J; Lindskog DM
Case Rep Surg; 2022; 2022():8440836. PubMed ID: 35402057
[No Abstract] [Full Text] [Related]
20. Fine-needle aspiration specimens of 3 cases of intra-abdominal Rosai-Dorfman disease with comprehensive review of the literature.
McIntire PJ; Kilic AI; Chen HH; Atieh M; Wojcik EM; Pambuccian SE
J Am Soc Cytopathol; 2019; 8(4):190-205. PubMed ID: 31272602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
